2018
DOI: 10.15171/jcvtr.2018.20
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn.

Abstract: Introduction: The Emblica officinalis (EO) fruit has traditionally been considered as a cardioactive medication and has demonstrated remarkable cardiovascular effects in the pharmacological literature. The present study systematically reviews EO’s potential for prevention and therapy of cardiovascular diseases (CVD). Methods: PubMed, ScienceDirect, Scopus, Proquest, Ebsco, Google, Google Scholar, Ovid, and Cochrane databases were searched from 1966 to 2017 for the English and non-English literature using the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(20 citation statements)
references
References 34 publications
0
19
0
Order By: Relevance
“…Components of CP— Amla, Neelkamal, Punarnawa, Pushkarmul, Kachur, Vasa, Bala, Sarivan, Pithawan, Barikateri and Gokshur —are well-recognized in their ability to rejuvenate and restore the cardiovascular system functions [92,93]. Amla has shown antiatherogenic, anticoagulant, hypolipidemic, antihypertensive, antioxidant, antiplatelet, and vasodilatory effects, as well as lipid deposition inhibitory properties [125]. In rat models, Punarnawa increased the reduced level of glutathione (GSH), superoxide dismutase (SOD) catalase (CAT) and decreased the elevated level of malondialdehyde (MDA) in cardiac tissue [126].…”
Section: Health Benefitsmentioning
confidence: 99%
“…Components of CP— Amla, Neelkamal, Punarnawa, Pushkarmul, Kachur, Vasa, Bala, Sarivan, Pithawan, Barikateri and Gokshur —are well-recognized in their ability to rejuvenate and restore the cardiovascular system functions [92,93]. Amla has shown antiatherogenic, anticoagulant, hypolipidemic, antihypertensive, antioxidant, antiplatelet, and vasodilatory effects, as well as lipid deposition inhibitory properties [125]. In rat models, Punarnawa increased the reduced level of glutathione (GSH), superoxide dismutase (SOD) catalase (CAT) and decreased the elevated level of malondialdehyde (MDA) in cardiac tissue [126].…”
Section: Health Benefitsmentioning
confidence: 99%
“…EO is rich in phenols (gallic acids, methyl gallate, ellagic acid, and trigalloyl glucose) and flavonoids (quercetin and kaempferol) [ 13 ]. Previous studies suggest that taking polyphenol-rich foods can have good effects on cardiovascular diseases including hypertension and endothelial and platelet functions [ 23 , 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…In a systematic review of Hashem-Dabaghian et al in 2018, the cardiovascular effects of this plant had been investigated [ 13 ]. According to the results of this review, EO has antiatherogenic, antihypertensive, anti-inflammatory, antioxidant, antiplatelet, vasodilator, and lipid deposition inhibitory effects.…”
Section: Introductionmentioning
confidence: 99%
“…Ingredients of CP such as Phyllanthus Emblica, Boerhavia diffusa, Inula racemose, Curcuma zedoaria, Sida cordifolia, Solanum virginianum and Tribulus Terrestris are well-known to revitalize and reinstate the functions of the cardiovascular system. Amlalki, the prime drug of CP, exhibits hypolipidemic, anticoagulant, antiatherogenic, antiplatelet, antihypertensive and vasodilatory effects (Hashem-Dabaghian et al, 2018).…”
Section: A Possible Role Of Chyawanprash In Management Of Covid-19mentioning
confidence: 99%